Robert H. Bell
Robert H. Bell
Vancouver Prostate Centre
Verified email at
Cited by
Cited by
Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer
AA Azad, SV Volik, AW Wyatt, A Haegert, S Le Bihan, RH Bell, ...
Clinical cancer research 21 (10), 2315-2324, 2015
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development
D Lin, AW Wyatt, H Xue, Y Wang, X Dong, A Haegert, R Wu, S Brahmbhatt, ...
Cancer research 74 (4), 1272-1283, 2014
Insulin receptor expression by human prostate cancers
ME Cox, ME Gleave, M Zakikhani, RH Bell, E Piura, E Vickers, ...
The Prostate 69 (1), 33-40, 2009
Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model
SL Krueckl, RA Sikes, NM Edlund, RH Bell, A Hurtado-Coll, L Fazli, ...
Cancer research 64 (23), 8620-8629, 2004
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
AV Lapuk, C Wu, AW Wyatt, A McPherson, BJ McConeghy, S Brahmbhatt, ...
The Journal of pathology 227 (3), 286-297, 2012
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
S Akamatsu, AW Wyatt, D Lin, S Lysakowski, F Zhang, S Kim, C Tse, ...
Cell reports 12 (6), 922-936, 2015
A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy
Z AbuGhosh, J Margolick, SL Goldenberg, SA Taylor, K Afshar, R Bell, ...
The Journal of urology 189 (4), 1326-1331, 2013
Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy
S Taylor, J Margolick, Z Abughosh, SL Goldenberg, D Lange, WR Bowie, ...
BJU international 111 (6), 946-953, 2013
Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T—quantitative correlation with biopsy
P Kozlowski, SD Chang, R Meng, B Mädler, R Bell, EC Jones, ...
Magnetic resonance imaging 28 (5), 621-628, 2010
Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression
S Ren, GH Wei, D Liu, L Wang, Y Hou, S Zhu, L Peng, Q Zhang, Y Cheng, ...
European urology 73 (3), 322-339, 2018
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer
AW Wyatt, F Mo, K Wang, B McConeghy, S Brahmbhatt, L Jong, ...
Genome biology 15 (8), 1-14, 2014
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
C Wu, AW Wyatt, AV Lapuk, A McPherson, BJ McConeghy, RH Bell, ...
The Journal of pathology 227 (1), 53-61, 2012
Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles
M Yu, D Zloty, B Cowan, J Shapiro, A Haegert, RH Bell, L Warshawski, ...
Journal of investigative dermatology 128 (7), 1797-1805, 2008
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
R Shrestha, N Nabavi, YY Lin, F Mo, S Anderson, S Volik, HH Adomat, ...
Genome medicine 11 (1), 1-12, 2019
Stromal gene expression is predictive for metastatic primary prostate cancer
F Mo, D Lin, M Takhar, VR Ramnarine, X Dong, RH Bell, SV Volik, ...
European urology 73 (4), 524-532, 2018
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
D Lin, X Dong, K Wang, AW Wyatt, F Crea, H Xue, Y Wang, R Wu, RH Bell, ...
Oncotarget 6 (3), 1806, 2015
A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer
SK Frees, J Aning, P Black, W Struss, R Bell, C Chavez-Munoz, M Gleave, ...
World journal of urology 36 (2), 215-220, 2018
Developing a highly specific biomarker for germ cell malignancies: plasma miR371 expression across the germ cell malignancy spectrum
L Nappi, M Thi, A Lum, D Huntsman, BJ Eigl, C Martin, B O’Neil, ...
Journal of Clinical Oncology 37 (33), 3090, 2019
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target
CC Collins, SV Volik, AV Lapuk, Y Wang, PW Gout, C Wu, H Xue, ...
Molecular cancer therapeutics 11 (3), 775-783, 2012
Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors
LA Wafa, J Palmer, L Fazli, A Hurtado-Coll, RH Bell, CC Nelson, ...
Human pathology 38 (1), 161-170, 2007
The system can't perform the operation now. Try again later.
Articles 1–20